pillbase.ru

BEOVU

Active substance: Brolucizumab

INJECTION, SOLUTION · BROLUCIZUMAB 6 mg/.05mL

United StatesActive

Marketing holder: Novartis Pharmaceuticals Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Визкью®
    раствор для внутриглазного введения, 120 мг/мл, 0.23 мл (original in Russian, GRLS)
    ЛП-№(009532)-(РГ-RU)
    Новартис Оверсиз Инвестментс АГ
  • Визкью®
    раствор для внутриглазного введения, 120 мг/мл, 0.23 мл (original in Russian, GRLS)
    ЛП-006598
    Новартис Оверсиз Инвестментс АГ
EU 1
  • Beovu
    brolucizumab
    EMEA/H/C/004913
    Novartis Europharm Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a66e-786d-b566-22e288691ae4,01a120c5-e50b-7bf3-bf10-39fe372e8a9a;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4882-791a-be3d-c1bdef88015b;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0078-0827
Registration status
Active
Dispensing
Prescription only
Route
INTRAVITREAL
Sources
  • product · openFDA NDC · 0078-0827 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0078-0827 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0078-0827 · Verified 2026-10-09 · open in source